Filtered By:
Vaccination: Cancer Vaccines
Countries: Hungary Health
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 171 results found since Jan 2013.
The Prevalence of High-Risk Human Papillomavirus in Hungary-A Geographically Representative, Cross-Sectional Study
Conclusion: Our study provides the first geographically representative genotype-specific hrHPV prevalence baseline database in Hungary to support policy-making efforts. Significant correlations with demographic data have transferable conclusions.PMID:35783359 | PMC:PMC9240187 | DOI:10.3389/pore.2022.1610424
Source: Pathology Oncology Research - July 5, 2022 Category: Pathology Authors: Andr ás István Fogarasi M árta Benczik Ágota Moravcsik-Kornyicki Adrienn Kocsis Anik ó Gyulai Zsigmond K ósa Source Type: research
Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study)
CONCLUSIONS: The HUN-VE 3 study demonstrated waning VE with all vaccine types for all examined outcomes during the Delta wave and confirmed the outstanding benefit of booster vaccination with the mRNA or Janssen vaccines, and this is the first study to provide clear and comparable effectiveness results for six different vaccine types after primary immunization against severe during the Delta pandemic wave.PMID:35935993 | PMC:PMC9353007 | DOI:10.3389/fimmu.2022.919408
Source: Cancer Control - August 8, 2022 Category: Cancer & Oncology Authors: Zolt án Vokó Zolt án Kiss Gy örgy Surján Orsolya Surj án Zs ófia Barcza Istv án Wittmann Gerg ő Attila Molnár D ávid Nagy Veronika M üller Krisztina Bogos P éter Nagy Istv án Kenessey Andr ás Wéber L őrinc Polivka Mih ály Pálosi J ános Source Type: research
COVID-19 and melanoma: a single center retrospective cohort study from Hungary
Magy Onkol. 2022 Jun 20;66(2):141-145. Epub 2022 May 21.ABSTRACTCOVID-19 pandemic affected the diagnosis and management of many diseases, including the most vulnerable group of patients with cancer. In this retrospective survey we evaluated the course of disease of patients treated for melanoma, who got infected with COVID-19 virus between March 2020 and April 2021. 382 patients had been treated for advanced melanoma in our center in this time period. 24 of them had been infected with coronavirus. Six of them suffered in stage III melanoma, the remaining 18 patients had stage IV disease. 14, 5 and 4 of the infected patient...
Source: Magyar Onkologia - June 20, 2022 Category: Cancer & Oncology Authors: T ímea Balatoni Mih ály Kispál Ildik ó Madurka Gabriella Liszkay Source Type: research
